Assyro AI

Orange Book product · Brand (NDA)

GLOPERBA

COLCHICINE

Brand (NDA)NDA 210942RX SCILEX PHARMS

At a glance

Jan 30, 2019

Approved

Brand (NDA)

Application

Not listed

TE code

6

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Jan 30, 2019

    7 yr 6 mo ago

  2. Today

  3. Patent 10383820 expires

    Listed drug product patent expiration.

    Nov 22, 2036

    in 10 yr 7 mo

  4. Patent 10383821 expires

    Listed drug product patent expiration.

    Nov 22, 2036

    in 10 yr 7 mo

  5. Patent 12274751 expires

    Listed method-of-use patent (U-2814) expiration.

    Nov 22, 2036

    in 10 yr 7 mo

  6. Patent 12514819 expires

    Listed method-of-use patent (U-2814) expiration.

    Nov 22, 2036

    in 10 yr 7 mo

  7. Patent 9907751 expires

    Listed drug product patent expiration.

    Nov 22, 2036

    in 10 yr 7 mo

  8. Patent 10226423 expires

    Listed drug product patent expiration.

    Dec 20, 2037

    in 11 yr 8 mo

Pharmaceutical detail

Active ingredient

COLCHICINE

Strength

0.6MG/5ML

Dosage form

SOLUTION

Route

ORAL

TE code

Not listed

Application

NDA 210942

Product number

001

Marketing status

RX

Reference listed drug (RLD)

Yes

Reference standard (RS)

Yes

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (6)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
10383820Nov 22, 2036in 10 yr 7 mo
ProductU-2814
10383821Nov 22, 2036in 10 yr 7 mo
Product
12274751Nov 22, 2036in 10 yr 7 mo
U-2814
12514819Nov 22, 2036in 10 yr 7 mo
U-2814
9907751Nov 22, 2036in 10 yr 7 mo
Product
10226423Dec 20, 2037in 11 yr 8 mo
Product
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.